Orthovita
This article was originally published in The Gray Sheet
Executive Summary
Synthetic, resorbable bone void filler Vitoss is launched in Europe, the firm announces Oct. 10. "We are delighted to offer surgeons a synthetic bone material that most closely resembles human bone," Maarten Persenaire, MD, VP-medical affairs, comments. A 510(k) is pending in the U.S
You may also be interested in...
OrthoVita's Vitoss Gains 510(k) Clearance, Will List For $600-700
OrthoVita's Vitoss synthetic cancellous bone void filler will list for about $600-700, a slight premium to other synthetic bone void fillers already on the market, the company said in announcing FDA 510(k) clearance on Dec. 15.
Prestige Expands UK Eye Care Range In Response To Consumer Demand
A “great consumer response” to TheraTears in the UK leads Prestige Consumer Healthcare to add TheraTears 5-in-1 Irritation and Redness eye drops to the range.